[Phase II study].

Abstract

It is 4 years since the Ministry of Health and Welfare of Japan introduced "The Guidelines on Clinical Evaluation for Anti-tumor Drugs" in February 1991. From the stand point that I have conducted several clinical studies on new anti-tumor drugs according to the Guidelines, this review pointed out some practical problems in the process to develop Phase II study based on the Guidelines.